License, Spin Out, or Walk Away
The three structural paths for a protected healthcare innovation and what each costs you. Licensing economics vs. equity positions. The incubator model. Time-to-revenue differences between devices and drugs. The founder’s illusion — equity that looks large on day one but dilutes to irrelevance.
This evolution is under development. Content will be available when the next cohort begins.